165 related articles for article (PubMed ID: 8719303)
1. GH responsiveness to repeated GHRH or hexarelin administration in normal adults.
Sartorio A; Conti A; Ferrero S; Spada A; Faglia G
J Endocrinol Invest; 1995 Oct; 18(9):718-22. PubMed ID: 8719303
[TBL] [Abstract][Full Text] [Related]
2. Galanin infusion partially restores the blunted growth hormone responses to repeated growth hormone releasing hormone stimuli in normal adults.
Sartorio A; Spada A; Conti A; Grugni G; Morabito F; Faglia G
J Endocrinol Invest; 1993 Feb; 16(2):95-8. PubMed ID: 7681861
[TBL] [Abstract][Full Text] [Related]
3. The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
Massoud AF; Hindmarsh PC; Matthews DR; Brook CG
Clin Endocrinol (Oxf); 1996 May; 44(5):555-62. PubMed ID: 8762732
[TBL] [Abstract][Full Text] [Related]
4. Different GH responsiveness to repeated GHRH administration in normal children and adults.
Sartorio A; Spada A; Morabito F; Faglia G
J Endocrinol Invest; 1988 Nov; 11(10):727-9. PubMed ID: 3148001
[TBL] [Abstract][Full Text] [Related]
5. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
Massoud AF; Hindmarsh PC; Brook CG
Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
[TBL] [Abstract][Full Text] [Related]
6. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man.
Micic D; Popovic V; Kendereski A; Peino R; Dieguez C; Casanueva FF
Clin Endocrinol (Oxf); 1996 Nov; 45(5):543-51. PubMed ID: 8977750
[TBL] [Abstract][Full Text] [Related]
7. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
Arvat E; Gianotti L; Grottoli S; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1994 Nov; 79(5):1440-3. PubMed ID: 7962341
[TBL] [Abstract][Full Text] [Related]
8. Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosa.
Popovic V; Micic D; Djurovic M; Obradovic S; Casanueva FF; Dieguez C
Clin Endocrinol (Oxf); 1997 May; 46(5):539-43. PubMed ID: 9231048
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man.
Arvat E; Di Vito L; Gianotti L; Ramunni J; Boghen MF; Deghenghi R; Camanni F; Ghigo E
Metabolism; 1997 Jan; 46(1):83-8. PubMed ID: 9005975
[TBL] [Abstract][Full Text] [Related]
10. Hexarelin induced growth hormone release is influenced by exogenous growth hormone.
Massoud AF; Hindmarsh PC; Brook CG
Clin Endocrinol (Oxf); 1995 Nov; 43(5):617-21. PubMed ID: 8548947
[TBL] [Abstract][Full Text] [Related]
11. Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man.
Arvat E; Maccagno B; Ramunni J; Gianotti L; Di Vito L; Deghenghi R; Camanni F; Ghigo E
J Endocrinol Invest; 1997 Mar; 20(3):122-7. PubMed ID: 9186817
[TBL] [Abstract][Full Text] [Related]
12. Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study.
Massoud AF; Hindmarsh PC; Brook CG
J Clin Endocrinol Metab; 1996 Dec; 81(12):4338-41. PubMed ID: 8954038
[TBL] [Abstract][Full Text] [Related]
13. Six-week treatment with hexarelin in young dogs: evaluation of the GH responsiveness to acute hexarelin or GHRH administration, and of the orexigenic effect of hexarelin.
Rigamonti AE; Cella SG; Marazzi N; Müller EE
Eur J Endocrinol; 1999 Sep; 141(3):313-20. PubMed ID: 10474131
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.
Ghigo E; Arvat E; Gianotti L; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F
J Clin Endocrinol Metab; 1994 Mar; 78(3):693-8. PubMed ID: 8126144
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamic control of growth hormone (GH) secretion in type I diabetic men: effect of the combined administration of GH-releasing hormone and hexarelin, a novel GHRP-6 analog.
Giustina A; Desenzani P; Perini P; Deghenghi R; Bugari G; Wehrenberg WB; Giustina G
Endocr Res; 1996 May; 22(2):159-74. PubMed ID: 8799695
[TBL] [Abstract][Full Text] [Related]
16. Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone.
Giustina A; Bonfanti C; Licini M; Ragni G; Stefana B
Regul Pept; 1997 May; 70(1):49-54. PubMed ID: 9250581
[TBL] [Abstract][Full Text] [Related]
17. Hexarelin stimulation of growth hormone release and mRNA levels in an infant and adult rat model of impaired GHRH function.
Torsello A; Luoni M; Grilli R; Guidi M; Wehrenberg WB; Deghenghi R; Müller EE; Locatelli V
Neuroendocrinology; 1997 Feb; 65(2):91-7. PubMed ID: 9067986
[TBL] [Abstract][Full Text] [Related]
18. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
[TBL] [Abstract][Full Text] [Related]
19. Galanin infusion restores the blunted GH responses to GHRH administration during GH treatment in children with constitutional growth delay.
Sartorio A; Conti A; Monzani M; Faglia G
J Endocrinol Invest; 1995 Feb; 18(2):109-12. PubMed ID: 7543124
[TBL] [Abstract][Full Text] [Related]
20. Effects of propranolol on GH responsiveness to repeated GH-releasing hormone stimulations in normal subjects.
Arosio M; Losa M; Bazzoni N; Bochicchio D; Palmieri E; Nava C; Faglia G
Acta Endocrinol (Copenh); 1990 Jun; 122(6):735-9. PubMed ID: 2115711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
